Aptevo Therapeutics Inc. (APVO) Capital expenditures 2016–2023
Aptevo Therapeutics Inc. (APVO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$29,000FY2023 · since FY2016: $1.5M → $29,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $29,000 | -95.9% |
| FY2022 | $713,000 | +710.2% |
| FY2021 | $88,000 | -42.5% |
| FY2020 | $153,000 | -84.3% |
| FY2019 | $976,000 | -30.4% |
| FY2018 | $1.4M | -44.2% |
| FY2017 | $2.5M | +64.5% |
| FY2016 | $1.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice